PREPARATION METHODS FOR A NOVEL GENERATION OF BIOLOGICAL SAFE KLH PRODUCTS USED FOR CANCER TREATMENT, FOR THE DEVELOPMENT OF CONJUGATED THERAPEUTIC VACCINES AND AS CHALLENGING AGENTS Russian patent published in 2019 - IPC A61K39/39 B01D15/36 C07K14/435 C07K1/18 

Abstract RU 2681413 C2

FIELD: biochemistry.

SUBSTANCE: method for the isolation and/or purification of hemocyanin is described, which includes a) providing the composition of hemocyanin, obtained from marine mollusk, the specified composition is a serum hemolymph; b) reducing conductivity of the composition provided in a) stage to a value of 30 mS/cm to 10 mS/cm by adding dilution buffer; c) applying a diluted formulation containing hemocyanin obtained in b) stage onto an anion exchange chromatography column; d) rinsing said column with hemocyanin purification buffer, preferably to remove salts and other proteins; e) and eluting hemocyanin from said column by adding a second buffer. In addition, a method for the isolation and/or purification of an immunocyanin is presented, including: a) providing the composition of hemocyanin, obtained from marine mollusk, the specified composition is a serum hemolymph; b) reducing conductivity of the composition provided in a) stage to a value of 30 mS/cm to 10 mS/cm by adding dilution buffer; c) applying a diluted formulation containing hemocyanin obtained in b) stage onto an anion exchange chromatography column; d) rinsing said column with hemocyanin purification buffer, preferably to remove salts and other proteins; e) dissociating hemocyanin into subunits by adding dissociation buffer with pH from 8 to 10, not containing Ca++ and Mg++ ions; and f) eluting the immunocyanin from said column by adding a second buffer. Use of an anion exchange chromatography column is also disclosed containing a matrix material with a particle size of more than 30 mcm and a pore size of 3,000 to 8,000 A (Angstrem) for purifying hemocyanin or subunits thereof from hemolymph serum.

EFFECT: invention allows to isolate and/or purify hemocyanin and subunits thereof using anion-exchange chromatography.

12 cl, 6 ex

Similar patents RU2681413C2

Title Year Author Number
PREPARATION METHODS FOR A NOVEL GENERATION OF BIOLOGICAL SAFE KLH PRODUCTS USED FOR CANCER TREATMENT, FOR THE DEVELOPMENT OF CONJUGATED THERAPEUTIC VACCINES AND AS CHALLENGING AGENTS 2014
  • Kottvits Ortvin
  • Shtifel Tomas
  • Muddukrishna Shammana N.
RU2672105C2
COMPOSITIONS OF CARBOHYDRATE VACCINE FOR INDUCING IMMUNE RESPONSES AND USES THEREOF IN CANCER TREATMENT 2014
  • Yuj Chen-Der Toni
  • Van Chen-Chi Iren
  • Li Vej-Khan
  • Lin Yuj-Chen
  • Lin Yuj-Khsin Tom
  • Chen I-Tszyuj
RU2666141C2
METHOD OF PREPARING IMMUNOGLOBULINS FOR INTRAVENOUS ADMINISTRATION AND OTHER IMMUNOGLOBULIN PREPARATIONS 1999
  • Laursen Inga
  • Tejsner Berge
RU2197500C2
FULL FLOW-THROUGH PROCESS FOR PURIFYING RECOMBINANT PROTEINS 2019
  • Duthe, Didier
  • Hemet, Celine
  • Mothes, Benoit
  • Pezzini, Jerome
RU2792435C2
IMPROVING IMMUNOGLOBULIN AFFINITY CHROMATOGRAPHY BY THE APPLICATION OF PRE-CAPTURE FLOCULATION 2020
  • Keszey, Zsuzsanna
  • Suto, Zoltan
RU2794431C1
METHOD OF PRODUCING BOTULINUM TOXIN 2016
  • Kim Kyoung-Yun
  • Kim Chung Sei
  • Kim Myung Seob
  • Sul Hye-Young
RU2707255C1
SEPARATION AND PURIFICATION OF WHEY COMPONENTS 2010
  • Skott Stiven Nial
  • Krishnapilej Ashok
RU2522491C2
PREPARATION OF ANTIBODY IgG AND METHOD OF ITS PRODUCTION 2005
  • Bukhakher Andrea
  • Iberer Gjunter
  • Remish Jurgen
RU2337109C2
AMYLOID CONJUGATE, ITS APPLICATIONS AND METHODS 2017
  • Sarasa Barrio Manuel
RU2712750C1
METHOD OF ALPHA-1-ANTITRYPSIN SOLUTION TREATMENT 2004
  • Shul'Ts Petra
  • Remish Jurgen
RU2370500C2

RU 2 681 413 C2

Authors

Kottvits Ortvin

Shtifel Tomas

Muddukrishna Shammana N.

Dates

2019-03-06Published

2014-06-12Filed